Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells.

Balasubramanian S, Venugopal P, Sundarraj S, Zakaria Z, Majumdar AS, Ta M.

Cytotherapy. 2012 Jan;14(1):26-33. doi: 10.3109/14653249.2011.605119. Epub 2011 Nov 18.

PMID:
22091833
2.

Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.

Batsali AK, Pontikoglou C, Koutroulakis D, Pavlaki KI, Damianaki A, Mavroudi I, Alpantaki K, Kouvidi E, Kontakis G, Papadaki HA.

Stem Cell Res Ther. 2017 Apr 26;8(1):102. doi: 10.1186/s13287-017-0555-9.

3.

Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.

Hsieh JY, Fu YS, Chang SJ, Tsuang YH, Wang HW.

Stem Cells Dev. 2010 Dec;19(12):1895-910. doi: 10.1089/scd.2009.0485. Epub 2010 Oct 12.

PMID:
20367285
4.

Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.

Reppel L, Schiavi J, Charif N, Leger L, Yu H, Pinzano A, Henrionnet C, Stoltz JF, Bensoussan D, Huselstein C.

Stem Cell Res Ther. 2015 Dec 30;6:260. doi: 10.1186/s13287-015-0263-2.

5.

Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.

Datta I, Mishra S, Mohanty L, Pulikkot S, Joshi PG.

Cytotherapy. 2011 Sep;13(8):918-32. doi: 10.3109/14653249.2011.579957. Epub 2011 Jun 22.

PMID:
21696238
6.

Netrin-1 acts as a non-canonical angiogenic factor produced by human Wharton's jelly mesenchymal stem cells (WJ-MSC).

Prieto CP, Ortiz MC, Villanueva A, Villarroel C, Edwards SS, Elliott M, Lattus J, Aedo S, Meza D, Lois P, Palma V.

Stem Cell Res Ther. 2017 Feb 28;8(1):43. doi: 10.1186/s13287-017-0494-5.

7.

Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.

Donders R, Bogie JFJ, Ravanidis S, Gervois P, Vanheusden M, Marée R, Schrynemackers M, Smeets HJM, Pinxteren J, Gijbels K, Walbers S, Mays RW, Deans R, Van Den Bosch L, Stinissen P, Lambrichts I, Gyselaers W, Hellings N.

Stem Cells Dev. 2018 Jan 15;27(2):65-84. doi: 10.1089/scd.2017.0029. Epub 2017 Dec 21.

PMID:
29267140
8.

Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.

Drela K, Lech W, Figiel-Dabrowska A, Zychowicz M, Mikula M, Sarnowska A, Domanska-Janik K.

Cytotherapy. 2016 Apr;18(4):497-509. doi: 10.1016/j.jcyt.2016.01.006.

PMID:
26971678
9.

Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly.

Amable PR, Teixeira MV, Carias RB, Granjeiro JM, Borojevic R.

Stem Cell Res Ther. 2014 Apr 16;5(2):53. doi: 10.1186/scrt442.

10.

Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.

Wang Q, Yang Q, Wang Z, Tong H, Ma L, Zhang Y, Shan F, Meng Y, Yuan Z.

Hum Vaccin Immunother. 2016;12(1):85-96. doi: 10.1080/21645515.2015.1030549.

11.

Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34(+) Transplants.

van der Garde M, van Pel M, Millán Rivero JE, de Graaf-Dijkstra A, Slot MC, Kleinveld Y, Watt SM, Roelofs H, Zwaginga JJ.

Stem Cells Dev. 2015 Nov 15;24(22):2649-59. doi: 10.1089/scd.2015.0138. Epub 2015 Oct 8.

12.

Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic context.

Reppel L, Margossian T, Yaghi L, Moreau P, Mercier N, Leger L, Hupont S, Stoltz JF, Bensoussan D, Huselstein C.

Curr Stem Cell Res Ther. 2014;9(4):306-18.

PMID:
24524785
13.

Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.

Shi Q, Gao J, Jiang Y, Sun B, Lu W, Su M, Xu Y, Yang X, Zhang Y.

Stem Cell Res Ther. 2017 Nov 2;8(1):246. doi: 10.1186/s13287-017-0700-5.

14.

Sonic hedgehog (SHH) signaling improves the angiogenic potential of Wharton's jelly-derived mesenchymal stem cells (WJ-MSC).

Zavala G, Prieto CP, Villanueva AA, Palma V.

Stem Cell Res Ther. 2017 Sep 29;8(1):203. doi: 10.1186/s13287-017-0653-8.

15.

Gene expression and protein secretion during human mesenchymal cell differentiation into adipogenic cells.

Amable PR, Teixeira MV, Carias RB, Granjeiro JM, Borojevic R.

BMC Cell Biol. 2014 Dec 20;15:46. doi: 10.1186/s12860-014-0046-0.

16.

DMSO- and Serum-Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord.

Shivakumar SB, Bharti D, Subbarao RB, Jang SJ, Park JS, Ullah I, Park JK, Byun JH, Park BW, Rho GJ.

J Cell Biochem. 2016 Oct;117(10):2397-412. doi: 10.1002/jcb.25563. Epub 2016 Jun 23.

17.

Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation.

Li X, Bai J, Ji X, Li R, Xuan Y, Wang Y.

Int J Mol Med. 2014 Sep;34(3):695-704. doi: 10.3892/ijmm.2014.1821. Epub 2014 Jun 25.

18.

Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.

Tantrawatpan C, Manochantr S, Kheolamai P, U-Pratya Y, Supokawej A, Issaragrisil S.

J Med Assoc Thai. 2013 Sep;96(9):1208-17.

PMID:
24163998
19.

Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.

Raicevic G, Najar M, Pieters K, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L.

Tissue Eng Part A. 2012 Jul;18(13-14):1410-8. doi: 10.1089/ten.TEA.2011.0434. Epub 2012 Apr 25.

PMID:
22429150
20.

Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.

Cardoso TC, Ferrari HF, Garcia AF, Novais JB, Silva-Frade C, Ferrarezi MC, Andrade AL, Gameiro R.

BMC Biotechnol. 2012 May 4;12:18. doi: 10.1186/1472-6750-12-18.

Supplemental Content

Support Center